Common Sensing develops and manufactures data-driven hardware and software solutions for people using injectable medicine.
Common Sensing develops and manufactures data-driven hardware and software medical device solutions for diabetes care that foster education and communication for patients while delivering decision support for clinicians. Common Sensing has a team of talented designers and engineers to develop Gocap™, a smart cap that turns existing injector pens into smart injectors.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 9, 2020 | Debt Financing | $1.42M | — | — | — | Detail |
| Apr 10, 2019 | Debt Financing | $2M | — | — | — | Detail |
| Apr 11, 2018 | Series A | $6.60M | 6 |
Waterline Ventures
|
— | Detail |
| Feb 20, 2018 | Debt Financing | $225K | — | — | — | Detail |
| Jun 16, 2016 | Debt Financing | $1.65M | — | — | — | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Waterline Ventures
|
Yes | Series A |
Life Sciences Angel Network
|
Yes | Seed |
Haselmeier
|
— | Series A |
Koninklijke Philips
|
— | Series A |
|
|
— | Series A |
Qualcomm Ventures
|
— | Series A |
Sanofi Ventures
|
— | Series A |